May 17, 2022 Comments Off on New patent for Genentech Inc drug ESBRIET Posted in: Patent Added Annual Drug Patent Expirations for ESBRIET Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are twenty-one patents…
The post New patent for Genentech Inc drug ESBRIET appeared first on Dr…
May 17, 2022 Comments Off on New patent expiration for Wyeth Pharms drug PROTONIX IV Posted in: Uncategorized
Annual Drug Patent Expirations for PROTONIX+IV Protonix Iv is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from two suppliers. There are three…
The post New patent expiration for Wyeth Pharms drug PROTONIX IV appeared fir…
